Xvivo Perfusion (Sweden) Today
| XVIVO Stock | SEK 438.00 2.50 0.57% |
PerformanceVery Weak
| Odds Of DistressLow
|
Xvivo Perfusion is selling for under 438.00 as of the 26th of February 2025; that is 0.57 percent increase since the beginning of the trading day. The stock's lowest day price was 433.5. Xvivo Perfusion has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Xvivo Perfusion AB , a medical technology company, provides solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. Xvivo Perfusion AB was founded in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. The company has 29.83 M outstanding shares. More on Xvivo Perfusion AB
Moving against Xvivo Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Xvivo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Xvivo Perfusion's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Xvivo Perfusion or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Director | Magnus Nilsson |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Xvivo Perfusion AB (XVIVO) is traded on Stockholm Exchange in Sweden and employs 133 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xvivo Perfusion's market, we take the total number of its shares issued and multiply it by Xvivo Perfusion's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Xvivo Perfusion AB operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 29.83 M outstanding shares.
Xvivo Perfusion AB has accumulated about 398.7 M in cash with (12.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.45.
Check Xvivo Perfusion Probability Of Bankruptcy
Ownership AllocationXvivo Perfusion AB retains a total of 29.83 Million outstanding shares. Over half of Xvivo Perfusion's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Xvivo Perfusion AB. Please watch out for any change in the institutional holdings of Xvivo Perfusion AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Xvivo Ownership Details
Xvivo Perfusion AB Risk Profiles
Although Xvivo Perfusion's alpha and beta are two of the key measurements used to evaluate Xvivo Perfusion's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.92 | |||
| Standard Deviation | 2.51 | |||
| Variance | 6.29 | |||
| Risk Adjusted Performance | (0.02) |
Xvivo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xvivo Perfusion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Xvivo Perfusion Corporate Management
Elected by the shareholders, the Xvivo Perfusion's board of directors comprises two types of representatives: Xvivo Perfusion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xvivo. The board's role is to monitor Xvivo Perfusion's management team and ensure that shareholders' interests are well served. Xvivo Perfusion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xvivo Perfusion's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jaya Tiwari | VP Affairs | Profile | |
| Katrin Gisselfalt | Global Director | Profile | |
| Charlotte Walldal | Global director | Profile | |
| Lena BSc | Chief Officer | Profile | |
| Andreas MD | Chief Officer | Profile | |
| Johan Holmstrom | Chief Officer | Profile |
Additional Tools for Xvivo Stock Analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.